Glyphosate Toxicology: What We Can Learn From the Current Controversy

View Sample PDF

Author(s): Sheldon Krimsky (Tufts University, USA)
Copyright: 2019
Pages: 14
Source title: Environmental Exposures and Human Health Challenges
Source Author(s)/Editor(s): Paraskevi Papadopoulou (Deree – The American College of Greece, Greece), Christina Marouli (Deree – The American College of Greece, Greece)and Anastasia Misseyanni (Deree – The American College of Greece, Greece)
DOI: 10.4018/978-1-5225-7635-8.ch015

Keywords: Medical Diagnosis and Practice / Medical Information Science Reference / Medicine & Healthcare / Public Health & Healthcare Delivery

Purchase

View Glyphosate Toxicology: What We Can Learn From the Current Controversy on the publisher's website for pricing and purchasing information.

Abstract

This chapter explores the glaring scientific differences in the human health assessment of the popular herbicide glyphosate between European and American institutions. The International Agency for Research on Cancer (IARC) classified glyphosate as a probable human carcinogen, while the U.S. Environmental Protection Agency (EPA) concluded that glyphosate is not likely to be carcinogenic to humans. Both IARC's and the EPA's carcinogenic risk assessment processes are discussed. This work reveals uncertainties in the sciences of toxicology and epidemiology, as well as assumptions made in their applications for evaluating glyphosate. These uncertainties, along with the political context of chemical risk assessment, are at the root of the divergent findings on the carcinogenic risks of glyphosate.

The IRMA Community

Research IRM

Glyphosate Toxicology: What We Can Learn From the Current Controversy

Purchase

Abstract

Related Content

IRMA Sponsors